HP and metabolic syndrome: In this study, these factors were limited to the study of CRP (a marker of inflammation), HbA1c (a marker of metabolic syndrome), and zonulin (a marker of intestinal permeability) which showed significant normalization after treatment but were not associated with the amount of, or changes in, SCFA levels.